SNDX

SyndaxB

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-22

View Chart

Peers tracked

U.S. public peers

Grade Position

Above peers

vs peer average

SNDX vs peer average

72/100

SNDX vs. peer average (B vs. C)

Grade spread

C 8 · D 2 · F 1

Graded peers loaded

Coverage

11 graded

100% of tracked

Peer overview

CLDX is the first available peer comparator.

Celldex is a similar-cap biotech with high clinical optionality, but it lacks Syndax's already-commercial dual-product revenue base; that makes CLDX more of a pipeline-risk comp than a direct commercial peer.

✓Peer source comes from the stored AI memo or peer model

✓Grades and factor rows use RankAlpha API data when available

✓Missing peer scores remain blank instead of being estimated

✓Side-by-side comparison keeps the data contract visible

Top peerCLDXCelldex Therapeutics

SNDX

Syndax

CLDX

Celldex Therapeutics

Grade

Momentum

Value

Sentiment

Setup Bias

Net —

Market Cap

Posture

Constructive

Mixed

Open Side-by-Side Comparison Compare all

Grade position vs CLDX

SNDX / CLDX

Grade Position

Above peers

SNDX vs. peer average (B vs. C)

72/100

Momentum

CLDX

Value

SNDX

Sentiment

SNDX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank

Ticker

Company

Grade

Grade score

vs SNDX

60/100

60/100

60/100

CareDx Inc Common

60/100

GHRS

GH Research Plc Common

60/100

CLDX is the first peer returned for this comparison set.